Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergTrump Targets $128 Billion ...
FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...
THE Philippines plans to import liquefied natural gas (LNG) from Alaska to meet its growing energy needs, the nation’s envoy ...
Vontobel Holding Ltd. grew its stake in Sprott Uranium Miners ETF (NYSEARCA:URNM – Free Report) by 12.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...
23h
Hosted on MSNAstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M DealBy selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results